These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia. Styczynski J; Pieters R; Huismans DR; Schuurhuis GJ; Wysocki M; Veerman AJ Br J Haematol; 2000 Sep; 110(4):813-8. PubMed ID: 11054062 [TBL] [Abstract][Full Text] [Related]
26. Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia. Miyachi H; Tanaka Y; Gondo K; Kawada T; Kato S; Sasao T; Hotta T; Oshima S; Ando Y Am J Hematol; 1999 Nov; 62(3):159-64. PubMed ID: 10539882 [TBL] [Abstract][Full Text] [Related]
27. Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia. Kaaijk P; Kaspers GJ; Van Wering ER; Broekema GJ; Loonen AH; Hählen K; Schmiegelow K; Janka-Schaub GE; Henze G; Creutzig U; Veerman AJ Br J Cancer; 2003 Mar; 88(5):775-81. PubMed ID: 12618889 [TBL] [Abstract][Full Text] [Related]
28. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia. Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149 [TBL] [Abstract][Full Text] [Related]
29. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome. Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131 [TBL] [Abstract][Full Text] [Related]
30. Pegylated asparaginase (Oncaspar) in children with ALL: drug monitoring in reinduction according to the ALL/NHL-BFM 95 protocols. Müller HJ; Löning L; Horn A; Schwabe D; Gunkel M; Schrappe M; von Schütz V; Henze G; Casimiro da Palma J; Ritter J; Pinheiro JP; Winkelhorst M; Boos J Br J Haematol; 2000 Aug; 110(2):379-84. PubMed ID: 10971395 [TBL] [Abstract][Full Text] [Related]
32. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia. Möhle R; Schittenhelm M; Failenschmid C; Bautz F; Kratz-Albers K; Serve H; Brugger W; Kanz L Br J Haematol; 2000 Sep; 110(3):563-72. PubMed ID: 10997965 [TBL] [Abstract][Full Text] [Related]
33. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894 [TBL] [Abstract][Full Text] [Related]
34. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations. Boos J; Werber G; Ahlke E; Schulze-Westhoff P; Nowak-Göttl U; Würthwein G; Verspohl EJ; Ritter J; Jürgens H Eur J Cancer; 1996 Aug; 32A(9):1544-50. PubMed ID: 8911116 [TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients. de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527 [TBL] [Abstract][Full Text] [Related]
36. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype. Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721 [TBL] [Abstract][Full Text] [Related]
37. Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase. Hlozkova K; Pecinova A; Alquezar-Artieda N; Pajuelo-Reguera D; Simcikova M; Hovorkova L; Rejlova K; Zaliova M; Mracek T; Kolenova A; Stary J; Trka J; Starkova J BMC Cancer; 2020 Jun; 20(1):526. PubMed ID: 32503472 [TBL] [Abstract][Full Text] [Related]
38. L-asparaginase in treatment of acute leukemia in children. Misíková Z; Cáp J Neoplasma; 1978; 25(1):133-9. PubMed ID: 273152 [TBL] [Abstract][Full Text] [Related]
39. Leukaemia cases in Central Hospital, Riyadh (Saudi Arabia). Khan MQ; Shivarudrappa AS; el-Bialy S; al-Khawagi MZ; al-Mofarreh M J Indian Med Assoc; 1991 Feb; 89(2):38-42. PubMed ID: 2056174 [TBL] [Abstract][Full Text] [Related]
40. Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance. Chen SH Pediatr Neonatol; 2015 Oct; 56(5):287-93. PubMed ID: 25603726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]